Exploring the morphological and functional retinal changes after dexamethasone intravitreal implant (Ozurdex®) in Macular Edema due to retinal vein occlusion

Ophthalmic Research

Volumn 51, Issue 3, 2014, Pages 153-160

  Parravano, Mariacristina ^a   Oddone, Francesco ^a   Boccassini, Barbara ^a   Giorno, Paola ^a   Chiaravalloti, Adele ^a   Tedeschi, Massimiliano ^a   Scarinci, Fabio ^a   Varano, Monica ^a  

^a IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

Dexamethasone; Intravitreal implant; Macular edema; Microperimetry; Retinal vein occlusion

Indexed keywords

DEXAMETHASONE;

ADULT; AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CENTRAL RETINAL THICKNESS; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; EYE EXAMINATION; FEMALE; HUMAN; IMAGE ANALYSIS; INTERVENTION STUDY; INTRAVITREAL IMPLANT; MALE; MEAN RETINAL SENSITIVITY; MICROPERIMETRY; PERIMETRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; RETREATMENT; SENSORY SYSTEM PARAMETERS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY; VISUAL IMPAIRMENT; MACULAR EDEMA; MORPHOLOGY; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; DRUG IMPLANTS; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL FIELDS;

EID: 84895932910     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000357275     Document Type: Article

References (29)

1. Yau JW, Lee P, Wong TY, Best J, Jenkins A: Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management. Intern Med J 2008; 38: 904-910.
2. Mitchell P, Smith W, Chang A: Prevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye Study. Arch Ophthalmol 1996; 114: 1243-1247.
3. Rehak J, Rehak M: Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res 2008; 33: 111-131.
4. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW: Vascular permeability in experimental diabetes is associated with reduced endothelial occluding content: vascular endothelial growth factor decreases occluding in retinal endothelial cells. Penn State Retina Research Group. Diabetes 1998; 47: 1953-1959.
5. Campochiaro PA, Hafiz G, Shah SM, Nguyen QD, Ying H, Do DV, Quinlan E, Zimmer- Galler I, Haller JA, Solomon SD, Sung JU, Hadi Y, Janjua KA, Jawed N, Choy DF, Arron JR: Ranibizumab for macular edema due to retinal vein occlusion: implication of VEGF as a critical stimulator. Mol Ther 2008; 16: 791-799.
6. Funatsu H, Yamashita H, Noma H, Mimura T, Yamashita T, Hori S: Increased levels of vascular endothelial growth factor and interleukin- 6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol 2002; 133: 70-77.
7. Rossetti L, Autelitano A: Cystoid macular edema following cataract surgery. Curr Opin Ophthalmol 2000; 11: 65-72.
8. Patel JI, Tombran-Tink J, Hykin PG, Gregor ZJ, Cree IA: Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: implications for structural differences in macular profiles. Exp Eye Res 2006; 82: 798-806.
9. SCORE Study Research Group: A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care versus Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 6. Arch Ophthalmol 2009; 127: 1115-1128.
10. Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY, Rubio RG; BRAVO Investigators: Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010; 117: 1102-1112.
11. Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, Rundle AC, Rubio RG, Murahashi WY; CRUISE Investigators: Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010; 117: 1124-1133.
12. Epstein DL, Algvere PV, von Wendt G, Seregard S, Kvanta A: Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study. Ophthalmology 2012; 119: 2587-2591.
13. Ramezani A, Entezari M, Moradian S, Tabatabaei H, Kadkhodaei S: Intravitreal triamcinolone for acute central retinal vein occlusion: a randomized clinical trial. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1601-1606.
14. SCORE Study Research Group: A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care versus Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 5. Arch Ophthalmol 2009; 127: 1101-1114.
15. Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Jumper JM, Figueroa M; SCORE Study Investigator Group: SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. Ophthalmology 2009; 116: 504-512.
16. Kuppermann BD, Blumenkranz MS, Haller JA, Williams GA, Weinberg DV, Chou C, Whitcup SM; Dexamethasone DDS Phase II Study Group: Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol 2007; 125: 309-317.
17. Haller J, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group: Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010; 117: 1134-1146.
18. Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM; Ozurdex GENEVA Study Group; Li J: Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 2011; 118: 2453-2460.
19. Coscas G, Coscas F, Zucchiatti I, Glacet-Bernard A, Soubrane G, Soued E: SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex . Eur J Ophthalmol 2011; 21: 631-636.
20. Parodi MB, Iacono P, Cascavilla M, Zucchiatti I, Bandello F: Compassionate use of dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion in a clinical setting. Acta Ophthalmol 2012; 90:e322-e323.
21. Querques L, Querques G, Lattanzio R, Gigante SR, Del Turco C, Corradetti G, Cascavilla ML, Bandello F: Repeated intravitreal dexamethasone implant (Ozurdex ) for retinal vein occlusion. Ophthalmologica 2013; 229: 21-25.
22. Parravano M, Oddone F, Tedeschi M, Chiaravalloti A, Perillo L, Boccassini B, Varano M: Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration treated with ranibizumab: 24-month results. Retina 2010; 30: 1017-1024.
23. Schneider U, Kuck M, Inhoffen W, Kreissig I: Fundus-controlled microperimetry with the scanning laser ophthalmoscope in macular diseases (in German). Klin Monatsbl Augenheilkd 1993; 203: 212-218.
24. Varano M, Scassa C: Scanning laser ophthalmoscope microperimetry. Semin Ophthalmol 1998; 13: 203-209.
25. Midena E, Radin PP, Pilotto E, Ghirlando A, Convento E, Varano M: Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularisation secondary to agerelated macular degeneration. A microperimetry study. Semin Ophthalmol 2004; 19: 55-61.
26. Schneider U, Inhoffen W, Gelisken F, Kreissig I: Assessment of visual function in choroidal neovascularization with scanning laser microperimetry and simultaneous indocyanine green angiography. Graefes Arch Clin Exp Ophthalmol 1996; 234: 612-617.
27. Tezel TH, Del Priore LV, Flowers BE, Grosof DH, Benenson IL, Zamora RL, Kaplan HJ: Correlation between scanning laser ophthalmoscope microperimetry and anatomic abnormalities in patients with subfoveal neovascularisation. Ophthalmology 1996; 103: 1829-1836.
28. Meyer LM, Schnfeld CL: Fast resolution of recurrent pronounced macular edema following intravitreal injection of dexamethasone 0.7 mg. Case Rep Ophthalmol 2011; 2: 246-250.
29. Yeh WS, Haller JA, Lanzetta P, Kuppermann BD, Wong TY, Mitchell P, Whitcup SM, Kowalski JW: Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. Ophthalmology 2012; 119: 1190-1198.